Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Crop Life Science's share price for the quarter that ended in Mar. 2026 was ₹41. Crop Life Science's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 24 Mil. Therefore, Crop Life Science's market cap for the quarter that ended in Mar. 2026 was ₹990 Mil.
Crop Life Science's quarterly market cap
declined
from Mar. 2025 (₹874 Mil) to Sep. 2025 (₹728 Mil) but then
increased
from Sep. 2025 (₹728 Mil) to Mar. 2026 (₹990 Mil).
Crop Life Science's annual market cap
increased
from Mar. 2024 (₹631 Mil) to Mar. 2025 (₹874 Mil) but then
declined
from Mar. 2025 (₹874 Mil) to Mar. 2026 (₹718 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Crop Life Science's Enterprise Value for Today is ₹1,304 Mil.
Crop Life Science (NSE:CLSL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Crop Life Science Market Cap Related Terms
Crop Life Science Market Cap Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Crop Life Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science Market Cap vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's Market Cap distribution charts can be found below:
* The bar in red indicates where Crop Life Science's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Crop Life Science's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a Market Cap of ₹737 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Crop Life Science and its competitors. According to the industry distribution chart, Crop Life Science ranks #234 out of 265 companies in the Agriculture industry, placing it in the top 88.3%.
Is Crop Life Science's Market Cap too high?
Crop Life Science's current Market Cap is ₹737 Mil. Based on the distribution chart, Crop Life Science ranks #234 out of 265 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Crop Life Science has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Market Cap compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #234 out of 265 companies for Market Cap. This places Crop Life Science in the lower half of its industry. The industry median Market Cap is 195.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Agriculture company?
The median Market Cap among Agriculture companies is 195.02, based on 265 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median Market Cap is 195.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current Market Cap is ₹737 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹54.88, compared to a current price of ₹43.00 — trading 21.6% below its estimated fair value. The current Market Cap is ₹737 Mil. Crop Life Science's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Market Cap is ₹737 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued.
The current stock price of ₹43.00 is trading 21.6% below its estimated GF Value™ of ₹54.88.
GuruFocus considers Crop Life Science to be Modestly Undervalued.
Key valuation signals for NSE:CLSL:
Market Cap: ₹737 Mil
GF Value™: ₹54.88 vs. price of ₹43.00 (21.6% below fair value)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
58GF Score
Get the complete analysis for NSE:CLSL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
